Axcellant participated in the PET Symposium 2025, held in Turku, marking 50 years of PET radiochemistry at the Turku PET Centre. The event offered a rich program—from tracer development to clinical applications in the nuclear medicine procedures, total‑body PET breakthroughs, and AI‑driven imaging strategies.
The dynamic exchange between seasoned experts, technologists, and early‑career researchers made it clear: innovation in nuclear medicine is accelerating.
Such forums go beyond technical curiosity: they are instrumental in shaping next‑generation diagnostics and refining trial design. Axcellant is energized by the practical insights gained and is already exploring how to integrate them into imaging‑based clinical research services.
We are committed to deepening our knowledge and strengthening our expertise in precision imaging, enabling us to continue delivering smarter, more effective trial solutions.
Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…
The FDA and the European Commission are changing the rules of the game simultaneously. The shift is from a single…
Modern nuclear medicine is a high-tech discipline that requires advanced facilities, infrastructure, qualified staff, and know-how. The reliable supply of radionuclides,…
Copyright @ 2026 Axcellant